Pregnancy outcomes after maternal exposure to fluconazole

Pharmacotherapy

Volumn 19, Issue 2, 1999, Pages 221-222

  Jick, Susan S ^a,b  

^a BOSTON UNIVERSITY MEDICAL CENTER   (United States)

^b BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FLUCONAZOLE; PYRROLE DERIVATIVE;

ARTICLE; CLEFT LIP; CLEFT PALATE; CONGENITAL DISORDER; CONGENITAL HEART MALFORMATION; CONTROLLED STUDY; FEMALE; FIRST TRIMESTER PREGNANCY; HUMAN; LIMB MALFORMATION; MAJOR CLINICAL STUDY; ORAL DRUG ADMINISTRATION; POLYDACTYLY; PREGNANCY COMPLICATION; PRENATAL DRUG EXPOSURE; SPINA BIFIDA; SYNDACTYLY; TOPICAL DRUG ADMINISTRATION; UROGENITAL TRACT DISEASE;

ABNORMALITIES, DRUG-INDUCED; ANTIFUNGAL AGENTS; FEMALE; FLUCONAZOLE; HUMANS; LIMB DEFORMITIES, CONGENITAL; PREGNANCY; PREGNANCY OUTCOME; PREGNANCY TRIMESTER, FIRST; PRENATAL EXPOSURE DELAYED EFFECTS;

EID: 0032949329     PISSN: 02770008     EISSN: None     Source Type: Journal    
DOI: 10.1592/phco.19.3.221.30919     Document Type: Article

References (3)

1. Pursley TJ, Blomquist IK, Abraham J, Andersen HF, Bartley JA. Fluconazole-induced congenital anomalies in three infants. Clin Infect Dis 1996;22:336-40.
2. Jick H, Jick SS, Derby LE. Validation of information recorded on general practitioner based computerised data resource in the United Kingdom. BMJ 1991;302:766-8.
3. Jick H, Terris BZ, Derby LE, Jick SS. Further validation of information recorded on a general practitioner based computerized data resource in the United Kingdom. Pharmacoepidemiol Drug Saf 1992,1:347-9.